Earnings Feed
Sign Up
Home/Filings/4/0001213900-18-005286
4//SEC Filing

MILLER CHRISTOPHER R. 4

Accession 0001213900-18-005286

CIK 0001416172other
View on SEC.govCompany Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 1:18 PM ET

Size

18.9 KB

Accession

0001213900-18-005286

Insider Transaction Report

Form 4
Period: 2017-08-31
NEXEON MEDSYSTEMS INCNXNN
MILLER CHRISTOPHER R.
INTERIM CFO
Transactions
  • Award

    COMMON STOCK

    2017-08-31$0.63/sh+2,996$1,873→ 255,796 total
  • Award

    COMMON STOCK

    2017-10-31$0.63/sh+2,996$1,873→ 267,780 total
  • Award

    COMMON STOCK

    2017-09-15$0.63/sh+2,996$1,873→ 258,792 total
  • Award

    COMMON STOCK

    2017-11-30$0.63/sh+2,996$1,873→ 273,772 total
  • Award

    OPTIONS

    2018-02-28+30,000→ 30,000 total
    Exercise: $0.76From: 2018-02-28Exp: 2021-02-28→ COMMON STOCK (30,000 underlying)
  • Award

    COMMON STOCK

    2017-09-30$0.63/sh+2,996$1,873→ 261,788 total
  • Award

    COMMON STOCK

    2017-12-15$0.63/sh+2,996$1,873→ 276,768 total
  • Award

    COMMON STOCK

    2017-10-15$0.63/sh+2,996$1,873→ 264,784 total
  • Award

    COMMON STOCK

    2017-11-15$0.63/sh+2,996$1,873→ 270,776 total
Footnotes (2)
  • [F1]On August 21, 2017, the Company offered to current employees the opportunity to purchase shares of the Company's restricted Common Stock for a discount through payroll deductions. Between August 31, 2017 and December 15, 2017, the Reporting Person acquired 23,968 shares of the Company's restricted common stock through a subscription of the shares as compensation for service as Chief Financial Officer of the Company. These shares were valued at $14,980 ($0.625 per share).
  • [F2]On February 28, 2018, and pursuant to the Company's 2016 Ominbus Incentive Plan, the Company granted to the Reporting Person an option (the "Option") to purchase 30,000 shares of the Company's restricted common stock, at a price of $0.76 per share, as compensation for service as Chief Financial Officer of the Company. The term of the Option shall be for a period of three (3) years from the date of issue. The fair value of the Option was determined to be $6,766 using the Black-Sholes Option Pricing Model. The Option was immediately exercisable at date of issue.

Documents

1 file

Issuer

NEXEON MEDSYSTEMS INC

CIK 0001416172

→
Entity typeother

Related Parties

1
  • filerCIK 0001456035

Filing Metadata

Form type
4
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 1:18 PM ET
Size
18.9 KB
View on SEC.gov